Literature DB >> 16723603

First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy.

Alessia Bertini, Alessandra Giordano, Paola Varesi, Laura Villa, Carlo Mancini, Alessandra Carattoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16723603      PMCID： PMC1479095          DOI： 10.1128/AAC.00166-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

1.  Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents.

Authors:  Juliana Coelho; Neil Woodford; Mariya Afzal-Shah; David Livermore
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 2.  OXA-type carbapenemases.

Authors:  Jan Walther-Rasmussen; Niels Høiby
Journal:  J Antimicrob Chemother       Date:  2006-01-30       Impact factor: 5.790

3.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe.

Authors:  Sophie Marqué; Laurent Poirel; Claire Héritier; Sylvain Brisse; Maria Dolores Blasco; Roxana Filip; Gabriela Coman; Thierry Naas; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.

Authors:  Claire Héritier; Anne Dubouix; Laurent Poirel; Nicole Marty; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2004-12-08       Impact factor: 5.790

Review 7.  The impact of carbapenemases on antimicrobial development and therapy.

Authors:  David M Livermore
Journal:  Curr Opin Investig Drugs       Date:  2002-02

8.  Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.

Authors:  Timothy R Walsh; Anne Bolmström; Anette Qwärnström; Ana Gales
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948
  8 in total
  8 in total

1.  Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.

Authors:  Maria Virginia Villegas; Juan Nicolas Kattan; Adriana Correa; Karen Lolans; Ana Maria Guzman; Neil Woodford; David Livermore; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

2.  Molecular characteristics and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China.

Authors:  Jing Ping Zhang; Wan Zhu; Su Fei Tian; Yun Zhuo Chu; Bai Yi Chen
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

3.  Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii.

Authors:  Alessia Bertini; Laurent Poirel; Sandrine Bernabeu; Daniela Fortini; Laura Villa; Patrice Nordmann; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 4.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

5.  Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97.

Authors:  Laurent Poirel; Wejdene Mansour; Olfa Bouallegue; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

Review 6.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 7.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

8.  In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy.

Authors:  Maria Lina Mezzatesta; Giusi Trovato; Floriana Gona; Vito Mar Nicolosi; Daria Nicolosi; Alessandra Carattoli; Giovanni Fadda; Giuseppe Nicoletti; Stefania Stefani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-02-08       Impact factor: 3.944
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.